title: Clinical activity of sorafenib in patients with advanced gastrointestinal stromal tumor bearing PDGFRA exon 18 mutation: a case series.
authors.affiliation: Departments of Medical Oncology.
authors.forename: G
authors.initials: G
authors.lastname: Roubaud
authors.affiliation: Departments of Radiology.
authors.forename: M
authors.initials: M
authors.lastname: Kind
authors.affiliation: Departments of Pathology, Institut Bergonié, Bordeaux, France.
authors.forename: J-M
authors.initials: JM
authors.lastname: Coindre
authors.affiliation: Department of Medicine and Pediatrics, Sarcoma Service, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: italiano@bergonie.org.
authors.forename: R G
authors.initials: RG
authors.lastname: Maki
authors.affiliation: Departments of Medical Oncology.
authors.forename: B
authors.initials: B
authors.lastname: Bui
authors.affiliation: Departments of Medical Oncology.
authors.forename: A
authors.initials: A
authors.lastname: Italiano
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D005091:Exons / Q000235:genetics; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D009154:Mutation; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib; D020796:Receptor, Platelet-Derived Growth Factor alpha